All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 26, 2021
Home » Blogs » BioWorld Perspectives » How to Pitch BioWorld: Five More Tips

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

How to Pitch BioWorld: Five More Tips

Sep. 1, 2011
By Trista Morrison
No Comments

If you read our post earlier this week (Top 5 Tips for Pitching BioWorld), you know what kind of news BioWorld Today covers. Here are five more helpful hints regarding how to work with us:

  1. How to contact us. Our direct phone numbers are on page two of BioWorld Today or here. Aside from the DC and science beats mentioned in Tip #4, we don’t specialize, so you can reach out to any of us. If you know your news is not cover-worthy (i.e. a patent, a personnel appointment, fast track or orphan drug designation, an early stage trial initiation, etc.), send it to newsdesk@bioworld.com. We check the newsdesk email all day, every day. It’s a good idea to cc newsdesk on any pitches in case the reporter you are targeting is out of the office.
  2. When we bite, reel us in. We don’t have a lot of time between when we assign stories at 10 a.m. EST and when they are due at 4:30 p.m. EST. If we contact you (PR firm) looking for an interview, please let us know right away that you got the message and are working on it. Otherwise we might think you’re out of the office and just contact your client directly, and if we can’t reach them, we might kill the story. Along these lines, if you’re going to issue a press release, make sure you have a spokesperson available. If the CEO will be on a plane all day, line up someone else who can talk to media.
  3. A note on going off the record. PR firms generally advise clients that there is no such thing as off the record. I did it when I was in PR, but as a reporter, I can tell you that’s definitely not true. At BioWorld, we depend on industry relationships, and we aren’t going to jeopardize those by printing something said off the record. Off-the-record conversations help us gather background information, and they help you build the relationship and keep us educated about your company. But remember that it’s vital to clarify the status of the discussion up front, not a day later.
  4. More on embargoes. I mentioned embargoes in Tip #3, but I want to mention them again because they are so critical to how BioWorld operates. We always honor embargoes. If you can tell us about your news a few days ahead of time, we can get a jump-start on our background research. Also, since our publication comes out late in the evening, some companies will work with us ahead of time and then let us publish the story the night before their press release crosses the wire, so folks wake up and see the press release and the BioWorld cover story on the same day. Offering us that kind of arrangement always gives your newsworthiness a boost.
  5. About clarifications and corrections. We want to be accurate, so don’t hesitate to ask for a correction if something is factually incorrect. But please don’t ask for a correction because we called your trial results “mixed” instead of “stunningly positive” when you missed three out of four endpoints. (Yes, this has happened).

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 25.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing